There have been several technological and pharmaceutical developments that have changed the way that deep vein thrombosis (DVT) is managed. DVTs remain a common and sometimes deadly problem, especially for patients who have limited mobility or are hospitalized. First line treatment options revolve around anticoagulation. For those patients with small DVTs relatable to a specific event such as a recent surgery this is often the only treatment necessary. Some patients have large blood clots in the upper legs and pelvis. While anticoagulation will help prevent progression of the blood clots, these patients may require thrombolysis or stent placement to help treat current DVTs and prevent future clots. For patients with recurrent DVTs despite adequate anticoagulation, IVC filter placement may be necessary to prevent pulmonary embolisms in the future.